Andre Witkin, MD
Retina Specialist · Boston, MANPI 1285811216
Payments from drug & device makers
Across 107 payments — averaging $9068.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$829K
- Genentech, Inc.$124K
- Genentech USA, Inc.$3K
- AbbVie$3K
- Cortigent Inc$3K
- Alcon$2K
- plus $6K from 18 others
What the payments were for
- Consulting fees$11,09549%
- Speaking & faculty fees$3,26214%
- Travel & lodging$8654%
- Food & beverage$4,98722%
- Gifts$2,50011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 14 | $829,389 |
| Genentech, Inc. | 20 | $123,589 |
| Genentech USA, Inc. | 11 | $3,339 |
| AbbVie(2 entities) | 7 | $3,166 |
| Cortigent Inc | 1 | $2,500 |
| Alcon | 11 | $1,835 |
| Apellis Pharmaceuticals, Inc. | 2 | $1,669 |
| Eyepoint US, Inc. | 1 | $1,620 |
| Bausch & Lomb Americas Inc. | 3 | $1,320 |
| Regeneron | 4 | $508 |
| Alimera Sciences, Inc. | 5 | $283 |
| Neurotech Pharmaceuticals, Inc. | 1 | $234 |
| Regeneron Healthcare Solutions, Inc. | 10 | $231 |
| Astellas Pharma US Inc | 3 | $188 |
| Sandoz | 3 | $103 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Sun Pharmaceutical Industries Inc. | 2 | $57 |
| Amgen(2 entities) | 2 | $50 |
| Coherus Oncology, Inc. | 1 | $35 |
| Oyster Point Pharma, Inc. | 1 | $27 |
| Dompe US, Inc. | 1 | $26 |
| Harrow Eye, LLC | 1 | $24 |
| Sight Sciences, Inc. | 1 | $24 |
| Tarsus Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUSVIMO$5,270
- OZURDEX$3,042
- Argus II Retinal Prosthesis System$2,500
- BEOVU$2,270
- Syfovre$1,669
- YUTIQ$1,620
- enVista MX60 IOL$1,275
- Constellation$601
- VABYSMO$417
- EYLEA HD$277
- Iluvien$221
- NGENUITY$146
- Izervay$129
- EYLEA$107
How this compares
$970,309 in reported general payments places this provider in the 95th percentile of 26 retina specialist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 110 | $4,007 |
| Brimonidine Tartrate | 30 | $2,940 |
| Ketorolac Tromethamine | 59 | $732 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 42 | $511 |
| Latanoprost | 65 | $378 |
| Atropine Sulfate | 11 | $250 |
| Timolol Maleate | 18 | $192 |
| ErythromycinErythromycin Base | 13 | $100 |
| Prednisone | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Boston
- Jeffrey HeierBoston$15.5M
- Chirag ShahBoston$526K
- Mohamed ElmasryBoston$25K
- Brian BalliosBoston$3K
- Ilya LeskovBoston$2K
- Siamak ShokrollahiBoston$806
- Omar AbdelalBoston$806
- Xiang WerdichBoston$686
- Tina ClearyBoston$184
- Miriam Englander Paschalis IliosBoston$170
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.